Patents by Inventor Massimo Resti

Massimo Resti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10141171
    Abstract: A method for individuating with high sensitivity and specificity ADA metabolites from dried blood spot. The method described herein can be used to extract Adenosine and Deoxyadenosine from a sample under conditions that permit concurrently extracting other metabolites, such as amino acids, free carnitine, or acylcarnitines. For example, harsh extraction conditions (such as extreme acidity and high temperature) can be avoided. The method can be used, along with other neonatal screenings, on blood samples and preferably on dried blood spots (Guthrie cards) and more preferably on Guthrie cards obtained in the II-IV day of life. The method is reliable and reproducible, easy to perform and gives a definitive response within a short time (1-2 days). One or more kits for use in the method of the disclosure are also described.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: November 27, 2018
    Assignee: AZIENDA OSPEDALIERO UNIVERSITARIA MEYER
    Inventors: Giancarlo La Marca, Chiara Azzari, Massimo Resti
  • Publication number: 20160172175
    Abstract: A method for individuating with high sensitivity and specificity ADA metabolites from dried blood spot. The method described herein can be used to extract Adenosine and Deoxyadenosine from a sample under conditions that permit concurrently extracting other metabolites, such as amino acids, free carnitine, or acylcarnitines. For example, harsh extraction conditions (such as extreme acidity and high temperature) can be avoided. The method can be used, along with other neonatal screenings, on blood samples and preferably on dried blood spots (Guthrie cards) and more preferably on Guthrie cards obtained in the II-IV day of life. The method is reliable and reproducible, easy to perform and gives a definitive response within a short time (1-2 days). One or more kits for use in the method of the disclosure are also described.
    Type: Application
    Filed: December 15, 2015
    Publication date: June 16, 2016
    Inventors: GIANCARLO LA MARCA, CHIARA AZZARI, MASSIMO RESTI
  • Patent number: 9234894
    Abstract: A method for individuating with high sensitivity and specificity ADA metabolites from dried blood spot. The method described herein can be used to extract Adenosine and Deoxyadenosine from a sample under conditions that permit concurrently extracting other metabolites, such as amino acids, free carnitine, or acylcarnitines. For example, harsh extraction conditions (such as extreme acidity and high temperature) can be avoided. The method can be used, along with other neonatal screenings, on blood samples and preferably on dried blood spots (Guthrie cards) and more preferably on Guthrie cards obtained in the II-IV day of life. The method is reliable and reproducible, easy to perform and gives a definitive response within a short time (1-2 days). One or more kit for use in the method.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: January 12, 2016
    Assignee: AZIENDA OSPEDALIERO UNIVERSITARIA MEYER
    Inventors: Giancarlo La Marca, Chiara Azzari, Massimo Resti
  • Publication number: 20120273671
    Abstract: A method for individuating with high sensitivity and specificity ADA metabolites from dried blood spot. The method described herein can be used to extract Adenosine and Deoxyadenosine from a sample under conditions that permit concurrently extracting other metabolites, such as amino acids, free carnitine, or acylcarnitines. For example, harsh extraction conditions (such as extreme acidity and high temperature) can be avoided. The method can be used, along with other neonatal screenings, on blood samples and preferably on dried blood spots (Guthrie cards) and more preferably on Guthrie cards obtained in the II-IV day of life. The method is reliable and reproducible, easy to perform and gives a definitive response within a short time (1-2 days). One or more kit for use in the method.
    Type: Application
    Filed: December 22, 2010
    Publication date: November 1, 2012
    Inventors: Giancarlo La Marca, Chiara Azzari, Massimo Resti
  • Publication number: 20100167272
    Abstract: The present invention relates to a method and kits thereof for detecting the presence and/or the specific serogroup of a prokaryote selected from the group consisting of & pneumionae, N. meningitidis, H. influenzae, Adenovirus, Klebsiella Pneumonite, Lysteria monocytogenes, Escherichia coli and Streptococcus agalactiae in a sample taken from a human being, through amplification of specific target regions.
    Type: Application
    Filed: July 11, 2008
    Publication date: July 1, 2010
    Applicant: UNIVERSITA' DEGLI STUDI DI FIRENZE
    Inventors: Chiara Azzari, Massimo Resti, Maria Moriondo